A novel panel of cerebrospinal fluid biomarkers for the differential diagnosis of Alzheimer's disease versus normal aging and frontotemporal dementia.
about
Monitoring CSF proteome alterations in amyotrophic lateral sclerosis: obstacles and perspectives in translating a novel marker panel to the clinicMultiplexed immunoassay panel identifies novel CSF biomarkers for Alzheimer's disease diagnosis and prognosisIdentification and validation of novel cerebrospinal fluid biomarkers for staging early Alzheimer's diseaseBiomarkers for cognitive impairment and dementia in elderly people.Glycoproteomics in neurodegenerative diseases.Biological function and clinical relevance of chromogranin A and derived peptides.Recent cerebrospinal fluid biomarker studies of Alzheimer's disease.Identification of a novel biomarker candidate, a 4.8-kDa peptide fragment from a neurosecretory protein VGF precursor, by proteomic analysis of cerebrospinal fluid from children with acute encephalopathy using SELDI-TOF-MSProtein markers for the differential diagnosis of vascular dementia and Alzheimer's disease.Peptidome analysis of cerebrospinal fluid by LC-MALDI MSAsparagine endopeptidase is an innovative therapeutic target for neurodegenerative diseases.Alterations of CSF cystatin C levels and their correlations with CSF Αβ40 and Αβ42 levels in patients with Alzheimer's disease, dementia with lewy bodies and the atrophic form of general paresisQuantitative label-free proteomics for discovery of biomarkers in cerebrospinal fluid: assessment of technical and inter-individual variation.Proteomic analysis of endoscopically (endoscopic pancreatic function test) collected gastroduodenal fluid using in-gel tryptic digestion followed by LC-MS/MS.Can proteomics yield insight into aging aorta?Why do so many drugs for Alzheimer's disease fail in development? Time for new methods and new practices?Cystatin C in Alzheimer's disease.Label-free quantitative LC-MS proteomics of Alzheimer's disease and normally aged human brains.The extended granin family: structure, function, and biomedical implicationsBiomarkers of basic activities of daily living in Alzheimer's disease.Novel diagnostic cerebrospinal fluid biomarkers for pathologic subtypes of frontotemporal dementia identified by proteomics.Proteomics of human neurodegenerative diseasesBiomarkers for Alzheimer disease in cerebrospinal fluid, urine, and blood.Primary progressive aphasia: clinicopathological correlations.Cerebrospinal fluid biomarkers for Alzheimer's disease: the present and the future.Use of proteomic methods in the analysis of human body fluids in Alzheimer research.Cerebrospinal fluid analysis in Alzheimer's disease: technical issues and future developments.Direct analytical sample quality assessment for biomarker investigation: qualifying cerebrospinal fluid samples.Cystatin C in aging and in Alzheimer's disease.Characteristics of C-terminal, β-amyloid peptide binding fragment of neuroprotective protease inhibitor, cystatin C.Protein clearance mechanisms of alpha-synuclein and amyloid-Beta in lewy body disorders.Alzheimer's disease biomarkers in animal models: closing the translational gap.Visualization of different characteristics of cerebrospinal fluid with acute encephalopathy and febrile seizures using pattern recognition analysis of 1H NMR.Evolving Relevance of Neuroproteomics in Alzheimer's Disease.Aberrant Levels of Cystatin C in Amyotrophic Lateral Sclerosis: a Systematic Review and Meta Analysis.
P2860
Q28483618-5672D00B-3787-4B4F-A2BC-F67CDC4A1353Q28740917-446DE2F4-4224-4BEB-9E24-75A4B12F6089Q28743561-FC84506E-9DA7-4A1E-85B0-DBF47C30474CQ30370745-9398AA57-3985-4557-9069-A5B6D9FC7FAFQ33563387-8A7D7D9F-C763-49F5-94BB-E4D491BC81DCQ33574106-0CC4B371-7872-4905-9D50-C60FE4057612Q33766323-6F64E35F-689C-411D-A30D-FCDDADB59D5FQ33992022-97DDC29F-55B4-4E3B-8CA3-CFE6AF346699Q34305901-E1E4BF3C-2310-49D3-A822-475758B7E45BQ34374324-30B776F4-E79C-4F0D-9ACA-2661103024A4Q34523642-8CE4CC20-B5DA-4836-8ACE-C19FCB2A0ABBQ34576418-5355D542-B547-430F-BD2F-9D03FE1826C2Q34735454-2D94B002-033F-4EED-9FE8-C7F8B528D0AFQ35535008-56BF917A-F212-48B0-9C99-3974724C66DBQ35598638-84B30459-F3C9-4CA1-BB7B-0A8FB25812A3Q36022784-1A76BDA4-3C89-4FE9-9A08-BC9EAA2D4449Q36078684-00B76FCD-074A-4DEB-8824-4EADBDAAA215Q36243522-E81745ED-FA62-4050-9817-C079C8C2C709Q36666413-97378A0C-58EB-4679-BB6E-EFF255342018Q36818214-3B31BD16-7A88-40BD-81BE-8018BAC005FBQ36934178-7BE0AAAC-6968-43A2-B70D-15BCA8B53A1DQ37260477-CB193521-0913-41A4-8C43-FC99157AB0ABQ37273675-08F20366-8970-42E4-A150-24CADE9ED867Q37688883-923BAB57-8FF7-45E9-AE19-EEF040695659Q37895052-09AC39D1-C71B-4FAA-8870-2F2C56BA0017Q38060574-073A481D-314A-435D-A967-0DC5387721C7Q38210117-AA54C658-191E-4039-9266-44C0374E2256Q38232016-3C19C220-A87A-448E-A749-48AD038C237BQ38873507-8B633F5C-2603-4298-A20E-2904FC769DBBQ39313522-BAA1DF41-B9A9-4670-99EE-84AB2B4B3E88Q41597801-91C4D719-B602-4C41-AA99-349DB95E41FFQ41822193-C6C1DAA9-C8AB-44C7-B090-597CAA92CBBAQ48505441-D4FE9776-73C9-4515-8F12-8B2028F8AC64Q50999408-5DD8B263-8BA1-4EBD-87BE-3ACB70E5BC10Q55513220-860D9AD4-AB90-4389-866D-565AB0E20B30
P2860
A novel panel of cerebrospinal fluid biomarkers for the differential diagnosis of Alzheimer's disease versus normal aging and frontotemporal dementia.
description
2007 nî lūn-bûn
@nan
2007 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
A novel panel of cerebrospinal ...... g and frontotemporal dementia.
@ast
A novel panel of cerebrospinal ...... g and frontotemporal dementia.
@en
A novel panel of cerebrospinal ...... g and frontotemporal dementia.
@nl
type
label
A novel panel of cerebrospinal ...... g and frontotemporal dementia.
@ast
A novel panel of cerebrospinal ...... g and frontotemporal dementia.
@en
A novel panel of cerebrospinal ...... g and frontotemporal dementia.
@nl
prefLabel
A novel panel of cerebrospinal ...... g and frontotemporal dementia.
@ast
A novel panel of cerebrospinal ...... g and frontotemporal dementia.
@en
A novel panel of cerebrospinal ...... g and frontotemporal dementia.
@nl
P2093
P2860
P921
P356
P1476
A novel panel of cerebrospinal ...... g and frontotemporal dementia.
@en
P2093
Hagnelius NO
Nilsson TK
Vassilopoulos D
P2860
P304
P356
10.1159/000110576
P577
2007-10-30T00:00:00Z